Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

por Barabutis, N, Schally, A V
Publicado 2008

Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.

por Bokser, L., Szende, B., Schally, A. V.
Publicado 1990

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers

por Bajo, A M, Schally, A V, Groot, K, Szepeshazi, K
Publicado 2004

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

por Chatzistamou, I, Schally, A V, Sun, B, Armatis, P, Szepeshazi, K
Publicado 2000

LHRH analogues and breast cancer.

por Korkut, E., Comaru-Schally, A. M., Schally, A. V., Plowman, P. N.
Publicado 1991

MSH-release inhibiting factors: recent studies.

por Kastin, A. J., Plotnikoff, N. P., Viosca, S., Anderson, M. S., Schally, A. V.
Publicado 1973

Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

por Kiaris, H, Schally, A V, Nagy, A, Sun, B, Armatis, P, Szepeshazi, K
Publicado 1999

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.

por Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P., Vadillo-Buenfil, M.
Publicado 1997

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.

por Pinski, J., Schally, A. V., Halmos, G., Szepeshazi, K., Groot, K., O'Byrne, K., Cai, R. Z.
Publicado 1994

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215

por Szereday, Z, Schally, A V, Nagy, A, Plonowski, A, Bajo, A M, Halmos, G, Szepeshazi, K, Groot, K
Publicado 2002

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

por Szepeshazi, K, Schally, A V, Groot, K, Armatis, P, Halmos, G, Hebert, F, Szende, B, Varga, J L, Zarandi, M
Publicado 2000

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions

por Murphy, L O, Cluck, M W, Lovas, S, Ötvös, F, Murphy, R F, Schally, A V, Permert, J, Larsson, J, Knezetic, J A, Adrian, T E
Publicado 2001

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado 1999

Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease?

por Bornstein, S R, Steenblock, C, Chrousos, G P, Schally, A V, Beuschlein, F, Kline, G, Krone, N P, Licinio, J, Wong, M L, Ullmann, E, Ruiz-Babot, G, Boehm, B O, Behrens, A, Brennand, A, Santambrogio, A, Berger, I, Werdermann, M, Sancho, R, Linkermann, A, Lenders, J W, Eisenhofer, G, Andoniadou, C L
Publicado 2018